Unknown

Dataset Information

0

Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway.


ABSTRACT: Stem cell-like tumor-repopulating cells (TRCs) have a critical role in establishing a tumor immunosuppressive microenvironment. However, means to enhance antitumor immunity by disrupting TRCs are absent. Our previous studies have shown that tumor cell-derived microparticles (T-MPs) preferentially abrogate TRCs by delivering antitumor drugs into nuclei of TRCs. Here, we show that low dose irradiation (LDI) enhances the effect of cisplatin-packaging T-MPs (Cis-MPs) on TRCs, leading to inhibiting tumor growth in different tumor models. This antitumor effect is not due to the direct killing of tumor cells but is T cell-dependent and relies on macrophages for their efficacy. The underlying mechanism is involved in therapeutic reprograming macrophages from tumor-promotion to tumor-inhibition by disrupting TRCs and curtailing their vicious education on macrophages. These findings provide a novel strategy to reset macrophage polarization and confer their function more like M1 than M2 types with highly promising potential clinical applications.

SUBMITTER: Sun Y 

PROVIDER: S-EPMC5486181 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway.

Sun Yanling Y   Zheng Zu'an Z   Zhang Huafeng H   Yu Yuandong Y   Ma Jingwei J   Tang Ke K   Xu Pingwei P   Ji Tiantian T   Liang Xiaoyu X   Chen Degao D   Jin Xun X   Zhang Tianzhen T   Long Zhixiong Z   Liu Yuying Y   Huang Bo B  

Oncoimmunology 20170331 6


Stem cell-like tumor-repopulating cells (TRCs) have a critical role in establishing a tumor immunosuppressive microenvironment. However, means to enhance antitumor immunity by disrupting TRCs are absent. Our previous studies have shown that tumor cell-derived microparticles (T-MPs) preferentially abrogate TRCs by delivering antitumor drugs into nuclei of TRCs. Here, we show that low dose irradiation (LDI) enhances the effect of cisplatin-packaging T-MPs (Cis-MPs) on TRCs, leading to inhibiting t  ...[more]

Similar Datasets

| S-EPMC5823939 | biostudies-literature
| S-EPMC4839324 | biostudies-other
2020-07-25 | GSE155008 | GEO
2023-09-01 | GSE224237 | GEO
| S-EPMC4839384 | biostudies-other
| S-EPMC3582771 | biostudies-literature
| S-EPMC4918378 | biostudies-literature